A paediatric case of successful non-myeloablative bone marrow transplantation after azacitidine therapy for non-Down syndrome acute megakaryoblastic leukaemia with monosomy 7

Yuhki Koga, Utako Oba, Wakako Kato, Hiroaki Ono, Kentaro Nakashima, Hidetoshi Takada

Research output: Contribution to journalArticle

Abstract

We report a patient with non-Down syndrome AML, also known as AMKL, with monosomy 7, who was also obese and had a hearing impairment and mental retardation. Non-myeloablative bone marrow transplantation was performed successfully after the patient received less aggressive azacitidine treatment, without the usual intensive induction chemotherapy regimen for AML.

Original languageEnglish
Pages (from-to)868-870
Number of pages3
JournalPediatric Transplantation
Volume20
Issue number6
DOIs
Publication statusPublished - Sep 1 2016

Fingerprint

Leukemia, Megakaryoblastic, Acute
Azacitidine
Bone Marrow Transplantation
Pediatrics
Induction Chemotherapy
Hearing Loss
Intellectual Disability
Therapeutics
Monosomy Chromosome 7

All Science Journal Classification (ASJC) codes

  • Pediatrics, Perinatology, and Child Health
  • Transplantation

Cite this

A paediatric case of successful non-myeloablative bone marrow transplantation after azacitidine therapy for non-Down syndrome acute megakaryoblastic leukaemia with monosomy 7. / Koga, Yuhki; Oba, Utako; Kato, Wakako; Ono, Hiroaki; Nakashima, Kentaro; Takada, Hidetoshi.

In: Pediatric Transplantation, Vol. 20, No. 6, 01.09.2016, p. 868-870.

Research output: Contribution to journalArticle

@article{cc6e45ea7d0b441d96c18e91684377e7,
title = "A paediatric case of successful non-myeloablative bone marrow transplantation after azacitidine therapy for non-Down syndrome acute megakaryoblastic leukaemia with monosomy 7",
abstract = "We report a patient with non-Down syndrome AML, also known as AMKL, with monosomy 7, who was also obese and had a hearing impairment and mental retardation. Non-myeloablative bone marrow transplantation was performed successfully after the patient received less aggressive azacitidine treatment, without the usual intensive induction chemotherapy regimen for AML.",
author = "Yuhki Koga and Utako Oba and Wakako Kato and Hiroaki Ono and Kentaro Nakashima and Hidetoshi Takada",
year = "2016",
month = "9",
day = "1",
doi = "10.1111/petr.12739",
language = "English",
volume = "20",
pages = "868--870",
journal = "Pediatric Transplantation",
issn = "1397-3142",
publisher = "Wiley-Blackwell",
number = "6",

}

TY - JOUR

T1 - A paediatric case of successful non-myeloablative bone marrow transplantation after azacitidine therapy for non-Down syndrome acute megakaryoblastic leukaemia with monosomy 7

AU - Koga, Yuhki

AU - Oba, Utako

AU - Kato, Wakako

AU - Ono, Hiroaki

AU - Nakashima, Kentaro

AU - Takada, Hidetoshi

PY - 2016/9/1

Y1 - 2016/9/1

N2 - We report a patient with non-Down syndrome AML, also known as AMKL, with monosomy 7, who was also obese and had a hearing impairment and mental retardation. Non-myeloablative bone marrow transplantation was performed successfully after the patient received less aggressive azacitidine treatment, without the usual intensive induction chemotherapy regimen for AML.

AB - We report a patient with non-Down syndrome AML, also known as AMKL, with monosomy 7, who was also obese and had a hearing impairment and mental retardation. Non-myeloablative bone marrow transplantation was performed successfully after the patient received less aggressive azacitidine treatment, without the usual intensive induction chemotherapy regimen for AML.

UR - http://www.scopus.com/inward/record.url?scp=84983383600&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84983383600&partnerID=8YFLogxK

U2 - 10.1111/petr.12739

DO - 10.1111/petr.12739

M3 - Article

C2 - 27384975

AN - SCOPUS:84983383600

VL - 20

SP - 868

EP - 870

JO - Pediatric Transplantation

JF - Pediatric Transplantation

SN - 1397-3142

IS - 6

ER -